Mathias Vinther, PhD, Partner, and Morgan Haller, MSc, Principal, will attend the LSX Investival Showcase 2026, taking place on 16 November at Old Billingsgate in London, UK.
The LSX Investival Showcase brings together more than 1,000 life sciences executives, investors and pharmaceutical leaders, alongside over 150 pioneering companies, for a day of presentations, strategic discussions, partnering and networking across biotech, medtech and digital health.
At 12:30, Mathias will join the panel discussion, “From Vision to Reality: US Market Entry and Public Market Pathways.” The session will explore strategies for establishing a presence in the US, navigating regulatory and financing pathways, and building sustainable growth in the world’s largest healthcare market.
Morgan will participate as an Investor Feedback Panelist for Growth Investments, offering presenting companies strategic guidance on their stories, pipelines and growth plans while helping them connect with investors actively seeking opportunities across the sector.